CD33 and neoplasm: LicMABs and antiCD33 mAb preferentially induced lysis of MOLM-13 cells in comparison to OCI-AML3 cells at both concentrations evaluated (10 μM and at the EC50), indicating that cells expressing high levels of CD33, such as tumor cells, are preferentially cleared (Supplementary Figure S2).